NM_001289104.2(PRKCSH):c.939GGA[7] (p.Glu323_Glu325del) AND not provided

Germline classification:: Benign/Likely benign (2 submissions)
Last evaluated:: Jan 17, 2024
Review status:: 2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV000885917.18

Allele description [Variation Report for NM_001289104.2(PRKCSH):c.939GGA[7] (p.Glu323_Glu325del)]

NM_001289104.2(PRKCSH):c.939GGA[7] (p.Glu323_Glu325del)

Gene:

PRKCSH:PRKCSH beta subunit of glucosidase II [Gene - OMIM - HGNC]

Variant type:

Microsatellite

Cytogenetic location:

19p13.2

Genomic location:

Preferred name:

NM_001289104.2(PRKCSH):c.939GGA[7] (p.Glu323_Glu325del)

HGVS:

NC_000019.10:g.11447528GGA[7]
NC_000019.10:g.11447528_11447530GGA[7]
NG_009300.1:g.17075GGA[7]
NM_001001329.3:c.939GGA[7]
NM_001289102.2:c.939GGA[7]
NM_001289103.2:c.939GGA[7]
NM_001289104.2:c.939GGA[7]MANE SELECT
NM_001379608.1:c.939GGA[7]
NM_001379609.1:c.939GGA[7]
NM_002743.3:c.939GGA[7]
NM_002743.3:c.960_968del
NP_001001329.1:p.Glu323_Glu325del
NP_001276031.1:p.Glu323_Glu325del
NP_001276032.1:p.Glu323_Glu325del
NP_001276033.1:p.Glu323_Glu325del
NP_001366537.1:p.Glu323_Glu325del
NP_001366538.1:p.Glu323_Glu325del
NP_002734.2:p.Glu323_Glu325del
NC_000019.9:g.11558341_11558349del
NC_000019.9:g.11558343GGA[7]
NM_002743.3:c.960_968del
NM_002743.3:c.960_968delGGAGGAGGA

Links:

dbSNP: rs3217229

NCBI 1000 Genomes Browser:

rs3217229

Molecular consequence:

NM_001001329.3:c.939GGA[7] - inframe_deletion - [Sequence Ontology: SO:0001822]
NM_001289102.2:c.939GGA[7] - inframe_deletion - [Sequence Ontology: SO:0001822]
NM_001289103.2:c.939GGA[7] - inframe_deletion - [Sequence Ontology: SO:0001822]
NM_001289104.2:c.939GGA[7] - inframe_deletion - [Sequence Ontology: SO:0001822]
NM_001379608.1:c.939GGA[7] - inframe_deletion - [Sequence Ontology: SO:0001822]
NM_001379609.1:c.939GGA[7] - inframe_deletion - [Sequence Ontology: SO:0001822]
NM_002743.3:c.939GGA[7] - inframe_deletion - [Sequence Ontology: SO:0001822]

Observations:

Condition(s)

Synonyms:: none provided
Identifiers:: MedGen: C3661900

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV001029394	Labcorp Genetics (formerly Invitae), Labcorp	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Likely benign (Jan 17, 2024)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]
SCV004137876	CeGaT Center for Human Genetics Tuebingen	criteria provided, single submitter (CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2)	Benign (Aug 1, 2022)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV001029394

Labcorp Genetics (formerly Invitae), Labcorp

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Likely benign
(Jan 17, 2024)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

SCV004137876

CeGaT Center for Human Genetics Tuebingen

criteria provided, single submitter

(CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2)

Benign
(Aug 1, 2022)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	yes	2	not provided	not provided	not provided	not provided	clinical testing
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001029394.5

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

From CeGaT Center for Human Genetics Tuebingen, SCV004137876.10

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	2	not provided	not provided	clinical testing	not provided

Description

PRKCSH: BS1, BS2

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	yes	not provided	not provided	not provided		2	not provided	not provided	not provided

Last Updated: Oct 20, 2024

ClinVar

Relating variation to medicine